furosemide has been researched along with indapamide in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (25.00) | 18.7374 |
| 1990's | 3 (12.50) | 18.2507 |
| 2000's | 6 (25.00) | 29.6817 |
| 2010's | 9 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Cecchi, A; Scozzafava, A; Supuran, CT; Temperini, C | 3 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Jouannetaud, MP; Lecornué, F; Liu, F; Maresca, A; Martin-Mingot, A; Supuran, CT; Thibaudeau, S | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Kyncl, J; Oheim, K; Seki, T; Solles, A | 1 |
| Arnfred, J; Hermansen, K; Mogensen, CE; Schmitz, O | 1 |
| Greenberg, A | 1 |
| Burke, TJ; Erickson, AL; Nobles, EM; Wolf, PS | 1 |
| Gomoll, AW; Hanson, RC; White, JB | 1 |
| Chan, JC; Cheung, CK; Cockram, CS; Law, LK; Nicholls, MG; Swaminathan, R | 1 |
| Hirata, H; Hosoya, M; Kashihara, N; Nishida, N; Ogura, T; Omiya, T; Ota, Z; Watanabe, H; Yamauchi, T | 1 |
| Baican, M; Coltau, M; Domuta, G; Hecht, A; Puscas, I | 1 |
| Fukatsu, A; Kimura, T; Muso, E; Nogaki, F; Nomura, K; Oida, E; Ono, T; Tanaka, M; Uemura, K; Yashiro, M | 1 |
| Bersten, AD; Bihari, S; Holt, AW; Prakash, S | 1 |
| Altaf, A; Jan, MU; Salahudin, M; Shah, H | 1 |
1 review(s) available for furosemide and indapamide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 trial(s) available for furosemide and indapamide
| Article | Year |
|---|---|
Factors determining the blood pressure response to enalapril and nifedipine in hypertension associated with NIDDM.
Topics: Albuminuria; Aldosterone; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diuretics; Double-Blind Method; Drug Therapy, Combination; Enalapril; Furosemide; Glycated Hemoglobin; Humans; Hypertension; Indapamide; Nifedipine; Placebos; Potassium; Regression Analysis; Renin; Sodium; Time Factors | 1995 |
The Na+-excreting efficacy of indapamide in combination with furosemide in massive edema.
Topics: Adult; Aged; Aged, 80 and over; Diuresis; Diuretics; Drug Therapy, Combination; Edema; Female; Furosemide; Humans; Indapamide; Male; Middle Aged; Nephrotic Syndrome; Sodium; Treatment Outcome | 2005 |
Addition of indapamide to frusemide increases natriuresis and creatinine clearance, but not diuresis, in fluid overloaded ICU patients.
Topics: Aged; Aged, 80 and over; Creatinine; Critical Care; Diuresis; Diuretics; Drug Therapy, Combination; Female; Furosemide; Humans; Hypernatremia; Indapamide; Intensive Care Units; Male; Middle Aged; Natriuresis; Prospective Studies; Sodium; Treatment Outcome | 2016 |
Comparing the sodium excreting efficacy of furosemide and indapamide combination against furosemide and metolazone combination in congestive heart failure patients: A randomized control trial.
Topics: Administration, Intravenous; Administration, Oral; Aged; Body Weight; Diuretics; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Humans; Indapamide; Male; Metolazone; Middle Aged; Pakistan; Sodium | 2019 |
19 other study(ies) available for furosemide and indapamide
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Carbonic anhydrase inhibitors. Interaction of indapamide and related diuretics with 12 mammalian isozymes and X-ray crystallographic studies for the indapamide-isozyme II adduct.
Topics: Animals; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Computer Simulation; Crystallography, X-Ray; Humans; Indapamide; Isoenzymes; Mice; Models, Molecular; Molecular Structure | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Carbonic anhydrase inhibitors. Comparison of chlorthalidone and indapamide X-ray crystal structures in adducts with isozyme II: when three water molecules and the keto-enol tautomerism make the difference.
Topics: Carbonic Anhydrase Inhibitors; Catalytic Domain; Chlorthalidone; Crystallography, X-Ray; Indapamide; Isoenzymes; Models, Molecular; Stereoisomerism; Water | 2009 |
Carbonic anhydrase inhibitors. Comparison of chlorthalidone, indapamide, trichloromethiazide, and furosemide X-ray crystal structures in adducts with isozyme II, when several water molecules make the difference.
Topics: Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Chlorthalidone; Crystallography, X-Ray; Furosemide; Indapamide; Isoenzymes; Structure-Activity Relationship; Sulfonamides; Trichlormethiazide; Water | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Carbonic anhydrases inhibitory effects of new benzenesulfonamides synthesized by using superacid chemistry.
Topics: Antimony; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Fluorides; Halogenation; Humans; Hydrofluoric Acid; Isoenzymes; Kinetics; Magnetic Resonance Spectroscopy; Neoplasm Proteins; Solutions; Sulfonamides | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Antihypertensive action of indapamide. Comparative studies in several experimental models.
Topics: Animals; Antihypertensive Agents; Aorta, Thoracic; Blood Pressure; Chlorthalidone; Diuretics; Dogs; Dose-Response Relationship, Drug; Female; Furosemide; Guinea Pigs; Hypertension; Hypertension, Renal; Indapamide; Lethal Dose 50; Male; Mice; Muscle Contraction; Nephrectomy; Rabbits; Rats; Rats, Inbred Strains; Spironolactone; Time Factors; Vena Cava, Inferior | 1975 |
Effects of furosemide and indapamide upon pancreatic insulin and somatostatin secretion in vitro.
Topics: Animals; Diuretics; Dogs; Dose-Response Relationship, Drug; Furosemide; In Vitro Techniques; Indapamide; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Somatostatin | 1986 |
What's new in diuretic therapy.
Topics: Acetazolamide; Acid-Base Imbalance; Biological Transport; Diuretics; Drug Resistance; Ethacrynic Acid; Furosemide; Humans; Hydrochlorothiazide; Hyperkalemia; Hypernatremia; Hypokalemia; Hyponatremia; Indapamide; Kidney Tubules, Distal; Kidney Tubules, Proximal; Loop of Henle; Metolazone; Osmolar Concentration; Spironolactone; Triamterene; Vasopressins | 1986 |
Effect of indapamide on volume-dependent hypertension, renal haemodynamics, solute excretion and proximal nephron fractional reabsorption in the dog.
Topics: Animals; Blood Pressure; Chlorides; Diuretics; Dogs; Dose-Response Relationship, Drug; Electrolytes; Female; Furosemide; Glomerular Filtration Rate; Hemodynamics; Hydrochlorothiazide; Hypertension; Indapamide; Kidney; Kidney Tubules, Proximal; Potassium; Renal Circulation; Sodium | 1983 |
Acute and chronic diuretic-induced alterations in urinary sodium and calcium excretion in the conscious rat.
Topics: Animals; Calcium; Chlorides; Diuretics; Dose-Response Relationship, Drug; Female; Furosemide; Hydrochlorothiazide; Indapamide; Muzolimine; Potassium; Rats; Rats, Inbred Strains; Sodium; Xipamide | 1982 |
[Diabetes mellitus and hypokalemia during indapamide and furosemide therapy].
Topics: Diabetes Mellitus; Diuretics; Furosemide; Humans; Hypokalemia; Indapamide; Male; Middle Aged | 1982 |
Alteration of renal receptors for atrial natriuretic peptide and vasopressin in spontaneously hypertensive rats treated with antihypertensive diuretics.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Furosemide; Hypertension; Indapamide; Kidney; Male; Radioligand Assay; Rats; Rats, Inbred SHR; Receptors, Atrial Natriuretic Factor; Receptors, Vasopressin; Trichlormethiazide | 1994 |
Vasodilatory effect of diuretics is dependent on inhibition of vascular smooth muscle carbonic anhydrase by a direct mechanism of action.
Topics: Acetazolamide; Aged; Amiloride; Animals; Blood Pressure; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Diuretics; Erythrocytes; Furosemide; Humans; Hydrochlorothiazide; Hydrogen-Ion Concentration; In Vitro Techniques; Indapamide; Middle Aged; Muscle, Smooth, Vascular; Rabbits; Triamterene; Vasodilation | 1999 |